Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer

CONCLUSIONS: In endometrial cancer, co-mutation of FAT3 and LRP1B not only leads to activation of the immune state, but also represents a subgroup with an improved prognosis, particularly in the MSI-H subtype.PMID:38696842 | DOI:10.1016/j.ygyno.2024.04.023
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research